Hyperactivation of extracellular signal-regulated kinase (ERK) by RAS-mediated signaling or inhibition of dual specificity phosphatase 6 (DUSP6) is associated with toxicity in lung adenocarcinoma cells with mutations in KRAS or EGFR
Arun M. Unni, Bryant Harbourne, Min Hee Oh, Sophia Wild, William W. Lockwood, Harold Varmus
The paper identifies ERK hyperactivation via RAS signaling or DUSP6 inhibition as toxic in KRAS or EGFR mutant lung adenocarcinoma cells, suggesting therapeutic strategies targeting feedback regulators.
bioRxiv · Nov 21, 2017 · PreprintCancer Biology